Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
1-609-252-5251+1-609-273-9656 or a target _blank href mailto:ken.dominski@bms.com ken.dominski@bms.com or JohnElicker Investor Relations +1-212-546-3775 or a target _blank href mailto:john.elicker@bms.com john.elicker@bms.com both ofBristol-Myers Squibb Company/ Web site: a target _blank href http://www.bms.com/ http://www.bms.com /